Skip to main content

Clinical Excellence

Access is everything.



With HCA, you tap into an expert network of care. From conducting large-scale clinical research with partners including Harvard Pilgrim Institute and the CDC, to using data from more than 26 million patient experiences each year, HCA is driven to help physicians discover and deliver predictive, precise and personalized medicine for their patients.


Powerful partners

Just as we partner with physicians to champion health, HCA partners with the brightest and the best to help improve medical practices and patient care. HCA founded a not-for-profit research institute Partnership for Advancing Clinical Excellence (PACE) which collaborates with academic institutions and funding agencies to advance medical knowledge and improve patient care through large-scale clinical research.


Creating a new standard of care

More than 40 HCA hospitals and 75,000 patients took part in an 18-month study to determine the best care approach to preventing MRSA infections in ICUs. The study, called REDUCE MRSA, found using antimicrobial soap and a nasal ointment on adult ICU patients reduces bloodstream infections, including MRSA, by 44 percent. The findings led to the creation of a new model of care, called universal decolonization, which all HCA hospitals adopted in 2013.

Following its publication in the New England Journal of Medicine, the REDUCE MRSA’s findings have gone on to set new standards in infection prevention across the country.


Big data answers big questions

As physicians, we depend on and benefit from patient care data in order to inform and improve future treatment. At HCA, we are fortunate to have access to data across 169 hospitals and 26 million patient encounters a year.

Recently, Dr. Jonathan B. Perlin, president, clinical services group and chief medical officer here at HCA, sat down with Eric Johnson, dean of the Vanderbilt Owen Graduate School of Management, to discuss the importance of big data and analytics in a learning health system, as well as patient data privacy and security concerns.


Life-changing discoveries

Sarah Cannon, the cancer institute of HCA, is providing physician-led and patient-centric care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center. The impact of this work is life-changing: HCA has been the clinical trial leader in approximately 80 percent of approved cancer therapies over the last 10 years, helping more patients benefit from better treatment options.


Championing healthy pregnancies

Are babies born prior to 39 weeks as healthy and robust as those born at 39 weeks and beyond? That was the driving question behind HCA’s research into the effects of elective delivery before 39 weeks. Since HCA delivers around 210,000 babies each year, we were able to gather data from 18,000 deliveries from 27 HCA-affiliated hospitals in only three months. Our research found early elective delivery before 39 weeks increased risk of illness, complications and admission to neonatal intensive care units (NICUs). With these findings, we created measures to reduce early elective deliveries at all HCA hospitals, and they worked.

HCA’s work to reduce elective deliveries before 39 weeks has led to similar efforts at hospitals across the country, helping to lessen elective early deliveries. By seeing the bigger picture, we developed changes that make all the difference, one baby at a time.